“…It is generally accepted that the central angiotensin II-induced cardiovascular and endocrine responses such as induction of drinking and dipsogenic effects, pressor response and release of AVP are mediated by AT 1 receptors [25,18]. Furthermore, central injection of AT 1 receptor antagonist, Losartan, blocks AT 1 receptors and influences on central angiotensin mechanisms [24,26]. Infusion of Ang II into a lateral cerebral ventricle produce an increase in blood pressure [27,20,28], increase in mean arterial pressure [29,30], decrease in urine flow [27], regulate hydromineral balance [22], induce the pressor response [31], stimulate AVP and OT release [20,28] and elevate RSNA (renal sympathetic nerve activity) [32].…”